Velocity Fund Partners

Scribenote is a technology company specializing in AI-driven medical scribe solutions for veterinarians. Its platform automates and simplifies the documentation process, reducing administrative tasks and allowing veterinarians to focus more on patient care. The system captures audio, generates transcripts, and creates SOAP notes during appointments, integrating seamlessly with practice management software. This streamlines workflows, enhances client experience, and improves overall efficiency in veterinary clinics.

MedMe Health is a patient care platform for pharmacies that enables scheduling, delivery, and tracking of clinical services at scale, both virtually and on-site. The platform uses proprietary algorithms to identify applicable medical services and supports online scheduling, digital documentation, and automated follow-up appointments, helping pharmacies streamline workflows and expand patient care capabilities. By integrating scheduling, documentation, and clinical services, the solution supports pharmacist-led care, strengthens patient relationships, and diversifies revenue streams across virtual and in-person settings.

InClinica, Inc. is a global contract research organization (CRO) that provides comprehensive clinical development and pharmaceutical research services to pharmaceutical, biotechnology, and medical device companies. Founded in 2007 and based in Wayne, Pennsylvania, the company specializes in various therapeutic areas, including oncology, metabolic diseases, inflammatory diseases, cardiovascular conditions, infectious diseases, gastroenterology, neuropsychiatry, pain management, rheumatology, women’s health, and ophthalmology. InClinica excels in all phases of clinical trials, particularly first-in-man and phase 2 studies, and operates internationally, with additional offices in Kuala Lumpur, Malaysia, the U.K., and Israel. The company offers expertise in site management, pharmacovigilance, and clinical research, helping clients navigate critical decisions in the development of their pharmaceutical assets. InClinica was previously known as IndiPharm Inc. until its rebranding in 2016.